QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 needham-maintains-buy-on-merit-medical-systems-raises-price-target-to-109

Needham analyst Mike Matson maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the price target from $105 t...

 merit-medical-systems-to-purchase-cook-medicals-lead-management-portfolio-in-200m-deal-seeks-to-enhance-its-position-in-cardiac-intervention-market

Merit Medical Systems plans to acquire Cook Medical's lead management portfolio for $210 million, aiming to boost its elect...

 merit-medical-anticipates-cook-medical-deal-to-be-modestly-dilutive-to-full-year-2024-non-gaap-profitability-given-partial-year-contribution

Lampropoulos continued: "We have updated our full-year 2024 financial guidance to include the projected impact of this acqu...

 merit-medical-signs-definitive-asset-purchase-deal-to-purchase-cook-medicals-lead-management-portfolio-for-total-cash-consideration-of-210m

Merit expects to fund the transaction through a combination of cash on hand and borrowings under its long-term credit facility....

 wells-fargo-maintains-equal-weight-on-merit-medical-systems-raises-price-target-to-103

Wells Fargo analyst Larry Biegelsen maintains Merit Medical Systems (NASDAQ:MMSI) with a Equal-Weight and raises the price t...

 merit-medicals-wrapsody-wave-trial-demonstrates-patency-vs-standard-of-care-in-av-fistula-patients

Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, today announced positive 6-month findings ...

 b-of-a-securities-maintains-neutral-on-merit-medical-systems-raises-price-target-to-103

B of A Securities analyst Craig Bijou maintains Merit Medical Systems (NASDAQ:MMSI) with a Neutral and raises the price targ...

 needham-reiterates-buy-on-merit-medical-systems-maintains-105-price-target

Needham analyst Mike Matson reiterates Merit Medical Systems (NASDAQ:MMSI) with a Buy and maintains $105 price target.

 piper-sandler-reiterates-overweight-on-merit-medical-systems-raises-price-target-to-110

Piper Sandler analyst Jason Bednar reiterates Merit Medical Systems (NASDAQ:MMSI) with a Overweight and raises the price tar...

 needham-maintains-buy-on-merit-medical-systems-raises-price-target-to-105

Needham analyst Mike Matson maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the price target from $94 to...

 b-of-a-securities-maintains-neutral-on-merit-medical-systems-raises-price-target-to-92

B of A Securities analyst Craig Bijou maintains Merit Medical Systems (NASDAQ:MMSI) with a Neutral and raises the price targ...

 piper-sandler-maintains-overweight-on-merit-medical-systems-raises-price-target-to-100

Piper Sandler analyst Jason Bednar maintains Merit Medical Systems (NASDAQ:MMSI) with a Overweight and raises the price targ...

 needham-maintains-buy-on-merit-medical-systems-raises-price-target-to-94

Needham analyst Mike Matson maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the price target from $93 to...

 merit-medical-to-present-6-month-outcomes-from-randomized-arm-of-wrapsody-arteriovenous-access-efficacy-pivotal-study-at-two-upcoming-medical-meetings

Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, today announced plans to release findings ...

 merit-medical-systems-q2-2024-adj-eps-092-beats-087-estimate-sales-33800m-beat-33455m-estimate

Merit Medical Systems (NASDAQ:MMSI) reported quarterly earnings of $0.92 per share which beat the analyst consensus estimate of...

 barrington-research-maintains-outperform-on-merit-medical-systems-maintains-100-price-target

Barrington Research analyst Michael Petusky maintains Merit Medical Systems (NASDAQ:MMSI) with a Outperform and maintains $1...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION